These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29126227)

  • 1. Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".
    Livadas S
    J Clin Endocrinol Metab; 2018 Jan; 103(1):360-361. PubMed ID: 29126227
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".
    Glintborg D; Rubin KH; Abrahamsen B; Andersen M
    J Clin Endocrinol Metab; 2018 Jan; 103(1):362-363. PubMed ID: 29126200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polycystic ovarian syndrome and diabetes].
    Carlsen SM; Salvesen KA; Vanky E; Fougner KJ
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2619-21. PubMed ID: 16215603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polycystic ovary syndrome: a disorder of insulin action and an increased risk for onset of non-insulin-dependent diabetes].
    Aganović I; Jelcić J; Kozić-Rukavina B
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():28-32. PubMed ID: 8759405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic ovary syndrome: significance of insulin resistance].
    Grott S; Algenstaedt P
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2261-6. PubMed ID: 14574641
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and polycystic ovary syndrome.
    Legro RS
    Fertil Steril; 2006 Jul; 86 Suppl 1():S16-7. PubMed ID: 16798276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives of insulin resistance and polycystic ovary syndrome.
    Pauli JM; Raja-Khan N; Wu X; Legro RS
    Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study.
    Bond R; Pace R; Rahme E; Dasgupta K
    Diabet Med; 2017 Dec; 34(12):1684-1695. PubMed ID: 28782842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome, a pathway to type 2 diabetes.
    Sir-Petermann T
    Nutrition; 2005; 21(11-12):1160-3. PubMed ID: 16308143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to insulin and polycystic ovary syndrome].
    Ducluzeau PH; Laville M; Vidal H; Pugeat M
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
    Sir-Petermann T; Angel B; Maliqueo M; Carvajal F; Santos JL; Pérez-Bravo F
    Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome and insulin resistance.
    Plosker SM
    Med Health R I; 2003 Jan; 86(1):12-5. PubMed ID: 12633015
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S; Guzick D
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.